TipRanks
55% OFF
PC:ACURA

AcuraStem

AcuraStem is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). By leveraging patient-based research, AcuraStem aims to revolutionize the treatment landscape for these challenging conditions.

Leadership & Board

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$12M
Total Funding Rounds
2
Latest Funding Amount
$8M
Latest Funding Round
Investment
Post-Money Valuation
―

Main Enterprise Clients

A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Apr 28, 2026Investment$7.50M―
Sep 03, 2024Investment$4.00M―

Investors

Investor NameFunding Round
California Institute for Regenerative MedicineInvestment

Similar Companies

A snapshot of private companies similar to AcuraStem, helping you discover and navigate related company profiles.

Related News and Analysis